Zucara Therapeutics
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1800-510 W Georgia St, Vancouver, Britis...Website
www.zucara.caRevenue
$6.6 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Zucara Therapeutics
Zucara Therapeutics is focused on improving diabetes treatments by developing a once-daily therapeutic aimed at preventing hypoglycemia in individuals with diabetes. Their unique technology seeks to restore the body's ability to counter-regulate low blood sugar, significantly enhancing diabetes management and patient quality of life. The company is backed by a team of experienced professionals and is addressing a critical unmet medical need in diabetes care. Zucara's innovative approach has the potential to transform the treatment landscape for diabetes patients.Explore more
Zucara Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zucara Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Zucara Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Zucara Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Zucara Therapeutics recently announced quarterly report
Click to see if Zucara Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Zucara Therapeutics has new funding data
Check if Zucara Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Zucara Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Zucara Therapeutics
Recommended Actions
Find VP level buyers at Zucara Therapeutics
Find more new buyers
Compare Similar Companies to Zucara Therapeutics
Compare insights from companies similar to Zucara Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Zucara Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Zucara Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zucara Therapeutics.
Zucara Therapeutics financials insights
Gather financial insights about Zucara Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$21M
2023
Other Financing Round
$2M
2024
Series B
$20M
Zucara Therapeutics Tech Stack
A closer look at the technologies used by Zucara Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Funding
Funding
Funding
Zucara Therapeutics News & Media
Zucara Therapeutics Announces Strategic Investment from Sanofi as Part of US$20 Million Series B Financing
- Sanofi and Existing Investor, Perceptive Advisors' PXV Fund I, Invested a combined US$20 million as part of the Financing – - Sanofi to Receive Exclusive Right of First Negotiation - - Proceeds to Fund Remainder of Phase 2a 'ZONE' Trial and Nonclinical Development of a Once-Weekly...Zucara Therapeutics Doses First Patient in Phase 2a 'ZONE' Trial
- ZONE study to evaluate the effect of ZT-01 on preventing nighttime hypoglycemia in people with Type 1 diabetes - - ZT-01 has the potential to become the first therapeutic to prevent nocturnal hypoglycemia, a condition for which there are currently no available therapies - TORONTO, Sept....Zucara Therapeutics Announces Additional Funding from JDRF to Support ZT-01 Phase 2 Study
- Award to provide US$2 million to support Zucara's planned Phase 2a ZONE trial, with first patient dosing expected in Q3 2023 - TORONTO, June 15, 2023 /PRNewswire/ - Zucara Therapeutics Inc., ("Zucara" or the "Company") a diabetes-focused life sciences company developing the first...Zucara Therapeutics Receives IND Clearance for Phase 2 Clinical Trial of ZT-01
- First patient dosing expected in Q3 2023 - - ZONE study to assess ZT-01's ability to prevent night-time hypoglycemia, a condition for which there are currently no available therapies - TORONTO, April 19, 2023 /PRNewswire/ - Zucara Therapeutics Inc., ("Zucara" or the "Company") a...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Zucara Therapeutics
Sign Up For FreeTo access detailed company insights
Zucara Therapeutics is focused on improving diabetes treatments by developing a once-daily therapeutic aimed at preventing hypoglycemia in individuals with diabetes. Their unique technology seeks to restore the body's ability to counter-regulate low blood sugar, significantly enhancing diabetes management and patient quality of life. The company is... Read More
